An international team of researchers has found that the use of selective serotonin reuptake inhibitor (SSRI) antidepressants during pregnancy is associated with an increased risk of gestational diabetes and early adaptation problems in newborns, even after taking maternal depression into account. The study also discovered that taking SSRI medication during pregnancy may reduce the risks of preterm birth and low birth weight. The work is published in the American Journal of Obstetrics & Gynecology MFM.